IONQ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
IONQ is not a good buy right now for a Beginner long-term investor with $50,000-$100,000 who wants to act immediately. The stock has strong momentum and positive long-term quantum-computing narrative, but it is already extended and technically overbought, making this a poor fresh-entry point. If the goal is to buy now rather than wait, the better choice is to hold off and not chase the current price.
IONQ is in a strong bullish trend: MACD histogram is positive and expanding, and the moving averages are aligned bullishly with SMA_5 > SMA_20 > SMA_200. However, RSI_6 at 83.638 signals the stock is overbought, which means the current move has likely run ahead of itself. Price is near resistance, with R1 at 68.288 already crossed in pre-market at 69.92-70.14, and the next key resistance is R2 at 74.414. This suggests upside remains possible, but the stock is stretched and vulnerable to short-term pullback.
["Strong revenue growth in the latest reported quarter: Q1 sales of $64.7 million, up 755% year-over-year.", "Recent analyst optimism remains in place, with multiple firms maintaining Buy/Outperform-type views and higher targets.", "Congress trading data shows 1 recent purchase and 0 sales, suggesting positive political sentiment.", "Technical trend remains bullish with strong moving-average alignment and positive MACD expansion.", "Similar candlestick pattern analysis suggests positive short-term follow-through probabilities."]
["RSI is deeply overbought, making the current price extended.", "Insiders are selling, with selling up 101.68% over the last month.", "Hedge funds are neutral, indicating no strong institutional accumulation trend.", "Wall Street price targets are mixed and the latest Morgan Stanley and JPMorgan targets are far below the current market price, suggesting valuation skepticism.", "The company still posted a large net loss in FY 2025 despite strong revenue growth.", "Option open interest shows more puts than calls, which tempers the bullish view."]
Latest quarter available: Q1. IonQ reported $64.7 million in sales, which was up 755% year-over-year, showing extremely strong growth momentum. The broader news also notes FY 2025 revenue of $130 million, up 202% year-over-year, but the company still generated a net loss of $512.1 million for FY 2025. That means growth is exceptional, but profitability is not yet established.
Analyst sentiment is constructive but divided. Jefferies is Buy with an $85 target, Northland initiated Outperform with a $55 target, and Mizuho remains Outperform with a $61 target. However, Morgan Stanley is Equal Weight with a $48.50 target, and JPMorgan is Neutral with a $50 target. The recent trend shows multiple target increases, but the presence of Neutral/Equal Weight ratings below the current price indicates Wall Street is not uniformly bullish. Overall, pros see strong scaling potential in quantum computing; cons remain focused on competition, execution risk, and valuation.
